We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Developing Guidance to Improve Multi-Site Trial Oversight
FDA Developing Guidance to Improve Multi-Site Trial Oversight
May 26, 2006
The FDA is developing guidance on the use of coordinators who are not principal investigators (PI) to improve supervision of multi-site clinical trials, an FDA official has announced.